Caribou Biosciences (CRBU) Debt Ratio (2020)

Caribou Biosciences (CRBU) reported Debt Ratio of 0.03 for Q4 2020.

Caribou Biosciences (CRBU) Debt Ratio (2020) Analysis & Trends

Caribou Biosciences (CRBU) has 1 years of Debt Ratio data on file, last reported at 0.03 in Q4 2020.

Debt Ratio for Q4 2020 came in at 0.03, changed N/A year-over-year; the trailing twelve-month figure through Dec 2020 was 0.03 (changed N/A YoY), and the FY2020 annual result was 0.03, changed N/A from the prior year.
Debt Ratio was little changed at 0.03 in Q4 2020 per CRBU's latest filing.
Over five years, Debt Ratio peaked at 0.03 in Q4 2020 and troughed at 0.03 in Q4 2020.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	0.18
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Caribou Biosciences	156.73 Mn	39.11 Mn	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2020	0.03